These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22922741)

  • 21. Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment.
    Cacciamani F; Salvadori N; Eusebi P; Lisetti V; Luchetti E; Calabresi P; Parnetti L
    Appl Neuropsychol Adult; 2018; 25(3):237-248. PubMed ID: 28631988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of 1H spectroscopy to a brief cognitive-functional test battery for the diagnosis of mild Alzheimer's disease.
    Silveira de Souza A; de Oliveira-Souza R; Moll J; Tovar-Moll F; Andreiuolo PA; Bottino CM
    Dement Geriatr Cogn Disord; 2011; 32(5):351-61. PubMed ID: 22311276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saccade deficits in amnestic mild cognitive impairment resemble mild Alzheimer's disease.
    Peltsch A; Hemraj A; Garcia A; Munoz DP
    Eur J Neurosci; 2014 Jun; 39(11):2000-13. PubMed ID: 24890471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Paired Associates Learning (PAL) Test: 30 Years of CANTAB Translational Neuroscience from Laboratory to Bedside in Dementia Research.
    Barnett JH; Blackwell AD; Sahakian BJ; Robbins TW
    Curr Top Behav Neurosci; 2016; 28():449-74. PubMed ID: 27646012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of executive dysfunction in amnestic mild cognitive impairment.
    Chen NC; Chang CC; Lin KN; Huang CW; Chang WN; Chang YT; Chen C; Yeh YC; Wang PN
    Int Psychogeriatr; 2013 Jul; 25(7):1181-9. PubMed ID: 23574879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ecological evaluation of executive functions in mild cognitive impairment and Alzheimer disease.
    da Costa Armentano CG; Porto CS; Nitrini R; Dozzi Brucki SM
    Alzheimer Dis Assoc Disord; 2013; 27(2):95-101. PubMed ID: 22828321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
    Egerházi A; Berecz R; Bartók E; Degrell I
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):746-51. PubMed ID: 17289240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).
    Lim YY; Jaeger J; Harrington K; Ashwood T; Ellis KA; Stöffler A; Szoeke C; Lachovitzki R; Martins RN; Villemagne VL; Bush A; Masters CL; Rowe CC; Ames D; Darby D; Maruff P
    Arch Clin Neuropsychol; 2013 Jun; 28(4):320-30. PubMed ID: 23552802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease.
    Blackwell AD; Sahakian BJ; Vesey R; Semple JM; Robbins TW; Hodges JR
    Dement Geriatr Cogn Disord; 2004; 17(1-2):42-8. PubMed ID: 14560064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of semantic orientation at encoding on free-recall performance in amnestic mild cognitive impairment and probable Alzheimer's disease.
    Hudon C; Villeneuve S; Belleville S
    J Clin Exp Neuropsychol; 2011 Jul; 33(6):631-8. PubMed ID: 21644138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
    Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
    Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qualitative patterns at Raven's colored progressive matrices in mild cognitive impairment and Alzheimer's disease.
    Ambra FI; Iavarone A; Ronga B; Chieffi S; Carnevale G; Iaccarino L; Cimminella F; Chiavazzo A; Garofalo E
    Aging Clin Exp Res; 2016 Jun; 28(3):561-5. PubMed ID: 26296535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using virtual reality to characterize episodic memory profiles in amnestic mild cognitive impairment and Alzheimer's disease: influence of active and passive encoding.
    Plancher G; Tirard A; Gyselinck V; Nicolas S; Piolino P
    Neuropsychologia; 2012 Apr; 50(5):592-602. PubMed ID: 22261400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of angiotensin-converting enzyme functional gene I/D polymorphism with amnestic mild cognitive impairment.
    Zhang Z; Deng L; Yu H; Shi Y; Bai F; Xie C; Yuan Y; Jia J; Zhang Z
    Neurosci Lett; 2012 Apr; 514(1):131-5. PubMed ID: 22405893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of visual recognition memory for the early diagnosis of Alzheimer's disease in patients over 75 years.
    Poissonnet A; Henry-Feugeas MC; Drunat O; Wolmark Y; Delpierre S; Koskas P
    Rev Neurol (Paris); 2012 Jun; 168(6-7):483-7. PubMed ID: 22405458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construct and diagnostic validities of the Free and Cued Selective Reminding Test in the Alzheimer's disease spectrum.
    Lemos R; Marôco J; Simões MR; Santana I
    J Clin Exp Neuropsychol; 2016 Oct; 38(8):913-24. PubMed ID: 27187087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease.
    Wang JH; Lv PY; Wang HB; Li ZL; Li N; Sun ZY; Zhao BH; Huang Y
    J Clin Neurosci; 2013 Aug; 20(8):1089-94. PubMed ID: 23787190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using artificial neural networks in clinical neuropsychology: high performance in mild cognitive impairment and Alzheimer's disease.
    Quintana M; Guàrdia J; Sánchez-Benavides G; Aguilar M; Molinuevo JL; Robles A; Barquero MS; Antúnez C; Martínez-Parra C; Frank-García A; Fernández M; Blesa R; Peña-Casanova J;
    J Clin Exp Neuropsychol; 2012; 34(2):195-208. PubMed ID: 22165863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.